IS7688A - Súlfónýlpíperídínafleiður sem innihalda arýl- eðaheteróarýlhóp til að nota sem hemla fyrir stoðefnismálmpróteasa - Google Patents

Súlfónýlpíperídínafleiður sem innihalda arýl- eðaheteróarýlhóp til að nota sem hemla fyrir stoðefnismálmpróteasa

Info

Publication number
IS7688A
IS7688A IS7688A IS7688A IS7688A IS 7688 A IS7688 A IS 7688A IS 7688 A IS7688 A IS 7688A IS 7688 A IS7688 A IS 7688A IS 7688 A IS7688 A IS 7688A
Authority
IS
Iceland
Prior art keywords
sulphonylpiperidine
propellant
inhibitors
aryl
heteroaryl group
Prior art date
Application number
IS7688A
Other languages
English (en)
Inventor
Nicholas Burrows Jeremy
Tucker Howard
Waterson David
Raymond Verschoyle Finlay Maurice
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS7688A publication Critical patent/IS7688A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96Sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IS7688A 2002-07-13 2005-02-08 Súlfónýlpíperídínafleiður sem innihalda arýl- eðaheteróarýlhóp til að nota sem hemla fyrir stoðefnismálmpróteasa IS7688A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0216383.0A GB0216383D0 (en) 2002-07-13 2002-07-13 Compounds
PCT/GB2003/002982 WO2004006926A1 (en) 2002-07-13 2003-07-09 Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitors

Publications (1)

Publication Number Publication Date
IS7688A true IS7688A (is) 2005-02-08

Family

ID=9940463

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7688A IS7688A (is) 2002-07-13 2005-02-08 Súlfónýlpíperídínafleiður sem innihalda arýl- eðaheteróarýlhóp til að nota sem hemla fyrir stoðefnismálmpróteasa

Country Status (16)

Country Link
US (1) US20060173041A1 (is)
EP (1) EP1539159A1 (is)
JP (1) JP2006501192A (is)
CN (1) CN1681503A (is)
AU (1) AU2003254441A1 (is)
BR (1) BR0312620A (is)
CA (1) CA2492086A1 (is)
GB (1) GB0216383D0 (is)
IL (1) IL165976A0 (is)
IS (1) IS7688A (is)
MX (1) MXPA05000519A (is)
NO (1) NO20050766L (is)
PL (1) PL375362A1 (is)
RU (1) RU2004138546A (is)
WO (1) WO2004006926A1 (is)
ZA (1) ZA200500208B (is)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE420068T1 (de) 2001-09-07 2009-01-15 Kaken Pharma Co Ltd Reverse hydroxamsäurederivate
AU2005318163B2 (en) * 2004-12-21 2011-12-01 Merck Serono Sa Sulfonyl amino cyclic derivatives and use thereof
EA013907B1 (ru) * 2005-10-26 2010-08-30 Мерк Сероно С.А. Сульфонамидные производные и их применение для модулирования металлопротеаз
KR101687144B1 (ko) * 2009-04-22 2016-12-15 액시킨 파마수티컬스 인코포레이티드 2,5-이치환된 아릴설폰아마이드 ccr3 길항제
EP2554544A1 (en) 2011-08-01 2013-02-06 Almirall, S.A. Pyridin-2(1h)-one derivatives as jak inhibitors
TWI679205B (zh) 2014-09-02 2019-12-11 日商日本新藥股份有限公司 吡唑并噻唑化合物及醫藥

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU570306B2 (en) * 1984-02-15 1988-03-10 Schering Corporation 8-chloro-6, 11-dihydro-11-(4-piperidylidene)-5h-benzo (5,6) cyclohepta (1,2-b) pyridine and its salts.
PL340551A1 (en) * 1997-11-12 2001-02-12 Darwin Discovery Ltd Derivatives of hydroxamic and carboxylic acids exhibiting mmp & tnf inhibitive action
EP1107953A1 (en) * 1998-08-29 2001-06-20 British Biotech Pharmaceuticals Limited Hydroxamic acid derivatives as proteinase inhibitors
GB9919776D0 (en) * 1998-08-31 1999-10-27 Zeneca Ltd Compoujnds
ES2208595T3 (es) * 2000-05-15 2004-06-16 Darwin Discovery Limited Derivados del acido hidroxamico.

Also Published As

Publication number Publication date
RU2004138546A (ru) 2005-09-10
CN1681503A (zh) 2005-10-12
JP2006501192A (ja) 2006-01-12
WO2004006926A1 (en) 2004-01-22
GB0216383D0 (en) 2002-08-21
BR0312620A (pt) 2005-04-26
US20060173041A1 (en) 2006-08-03
AU2003254441A1 (en) 2004-02-02
MXPA05000519A (es) 2005-03-23
IL165976A0 (en) 2006-01-15
EP1539159A1 (en) 2005-06-15
ZA200500208B (en) 2005-10-20
NO20050766L (no) 2005-04-11
PL375362A1 (en) 2005-11-28
CA2492086A1 (en) 2004-01-22

Similar Documents

Publication Publication Date Title
NO20054880D0 (no) Azaspiroalkanderivater som inhibitorer av metallproeaser
ATE370142T1 (de) Triazolopyrimidinderivate als inhibitoren von glycogensynthasekinase-3
CY2016042I2 (el) Νεες ετεροκυκλικες ενωσεις δραστικες ως αναστολεις των βητα-λακταμασων
IL169691A0 (en) Malonamide derivatives as gamma-secretase inhibitors
NO20043642L (no) Heterocykiske tripeptider som hepatitt C inhibitorer
AP1967A (en) Thiazolidinone compounds as inhibitors of Hyak3
NO20043726L (no) Heteroarylforbindelser anvendelige som inhibitorer av GSK-3
IS7717A (is) Pýrídasínónafleiður sem PDF4-hemlar
IL179844A0 (en) Five-membered heterocycles useful as serine protease inhibitors
NO20014837D0 (no) Pyrazolsammensetninger nyttige som inhibitorer av ERK
SI1492785T1 (sl) 2-hidroksi-3-heteroarilindolni derivati kot inhibitorji GSK3
ATE333463T1 (de) Selektive dipeptidische inhibitoren von kallikrein
HK1095594A1 (en) 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease
IL183188A0 (en) Pyrrolidyl derivatives of heteroaromatic compounds as phosphodiesterase inhibitors
TW200635587A (en) Inducible nitric oxide synthase dimerization inhibitors
IS7688A (is) Súlfónýlpíperídínafleiður sem innihalda arýl- eðaheteróarýlhóp til að nota sem hemla fyrir stoðefnismálmpróteasa
ZA200701583B (en) Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1
IS8201A (is) Nikótínamíð afleiður gagnlegar sem PDE4 hindrar
NO20062978L (no) Reduksjon av dermal arrdannelse
AU2003257991A1 (en) Fluorinated phenyl-naphthalenyl-urea compounds as inhibitors of cytokines involved in inflammatory processes
ATE427953T1 (de) Fondaparinux- natrium zusammenstellung von hoher reinheit
DK1317421T3 (da) 2-amino-2-alkyl-5-heptensyre- og heptynsyrederivater der er nyttige som nitrogenoxidsynthaseinhibitorer
ATE440821T1 (de) Isochinolinderivate als mao-b inhibitoren
ATE382048T1 (de) Pyrazolopyrimdine als hemmstoffe cyclin abhängiger kinasen
ATE384530T1 (de) 4-aminochinolin-3-carbonsäureamid-derivate als pde4-hemmer